Systematic Review of Vaccination Guidance in Multiple Sclerosis
This systematic review analyzed 12 documents on vaccination guidelines for chronic neurological disorders, finding that multiple sclerosis had the most comprehensive guidance regarding vaccination prior to disease-modifying therapy, the use of live attenuated vaccines, and considerations for timing during immunosuppression or relapse.
- Tags
- #Other
- Most relevant to
- —
Why it matters
Having clear and detailed vaccination guidelines for multiple sclerosis is crucial to ensure effective disease management and protection against illness. However, existing guidance remains heterogeneous and may not adequately support clinical decisions.
What this does not prove
The review highlights that official immunization guidance for individuals with chronic neurological disorders, including multiple sclerosis, is still limited and inconsistent, indicating a need for updated and clearer recommendations.
Next milestone
No next milestone was established from the available source.
Study facts
- Study design
- Systematic review
- Participants / samples
- 12 · basis not reported
- Randomised
- Not reported
- Controlled
- Not reported
- Primary endpoint met
- Not reported
- Relevant MS type
- All
- Publication date
- 2026-09-05
- Evidence reviewed
- Abstract only
- Regulatory approval
- Not reported
- Research areas
- Other
Original sources
- Primary evidenceGuidelines on Immunization of People with Chronic Neurological Disorders: A Systematic Review. ↗DOI: 10.3390/vaccines14090777
Supporting passages (8)
study designThis systematic review aimed to identify and describe official guidelines on preventive active immunization for individuals with chronic neurological disorders.
subjectsOverall, 12 unique documents were included.
sample sizeOverall, 12 unique documents were included.
research categoriesThis systematic review aimed to identify and describe official guidelines on preventive active immunization for individuals with chronic neurological disorders.
relevant ms typesMultiple sclerosis was the condition with the most detailed guidance, especially regarding vaccination before disease-modifying therapies, live attenuated vaccines, vaccine timing in relation to immunosuppression or relapse, and protection of close contacts.
findingsMultiple sclerosis was the condition with the most detailed guidance, especially regarding vaccination before disease-modifying therapies, live attenuated vaccines, vaccine timing in relation to immunosuppression or relapse, and protection of close contacts.
limitationsOfficial immunization guidance for people with chronic neurological disorders remains limited and heterogeneous. Future guidelines should provide clearer and regularly updated recommendations to support vaccination assessment, treatment-sensitive planning, and multidisciplinary coordination.
publication datePublication date: 2026-09-05
AI assessment, not yet reviewed by a person · version 1 · Community votes are separate from evidence review.